Methadone News and Research

RSS
AAN releases new position statement on opioids for chronic non-cancer pain

AAN releases new position statement on opioids for chronic non-cancer pain

FDA approves Contrave extended-release tablets for chronic weight management

FDA approves Contrave extended-release tablets for chronic weight management

Low dose of opioids including methadone effective for treatment of testosterone suppression

Low dose of opioids including methadone effective for treatment of testosterone suppression

Researchers focus on how exposure to opioids may alter expression of OPRM1 gene

Researchers focus on how exposure to opioids may alter expression of OPRM1 gene

New therapeutic drug may prevent respiratory depression in patients taking opioid medication

New therapeutic drug may prevent respiratory depression in patients taking opioid medication

Rockefeller scientists identify protein that makes breast cancer cells more likely to metastasize

Rockefeller scientists identify protein that makes breast cancer cells more likely to metastasize

Prescription drug deaths drop in Fla. after crackdown on doctors

Prescription drug deaths drop in Fla. after crackdown on doctors

State highlights: Ohio managed care plans launch; Bluecross Blueshield plan faces Ore. lawsuit; N.Y. policy on unvaccinated children upheld

State highlights: Ohio managed care plans launch; Bluecross Blueshield plan faces Ore. lawsuit; N.Y. policy on unvaccinated children upheld

Researchers find sharp increase in deaths from commonly prescribed painkillers in US, Canada

Researchers find sharp increase in deaths from commonly prescribed painkillers in US, Canada

Janssen, Viiv Healthcare to develop single tablet regimen for maintenance treatment of HIV

Janssen, Viiv Healthcare to develop single tablet regimen for maintenance treatment of HIV

BioDelivery Sciences receives approval of NDA for BUNAVAIL from FDA

BioDelivery Sciences receives approval of NDA for BUNAVAIL from FDA

State highlights: NYC plan for treating mentally ill; Kan. town gets abortion services again; Iowa medical marijuana

State highlights: NYC plan for treating mentally ill; Kan. town gets abortion services again; Iowa medical marijuana

Braeburn announces new clinical trial for Probuphine based on clear guidance from FDA

Braeburn announces new clinical trial for Probuphine based on clear guidance from FDA

HHS calls health care providers to expand use of medications to treat opioid addiction, reduce overdose deaths

HHS calls health care providers to expand use of medications to treat opioid addiction, reduce overdose deaths

State highlights: Home care workers' pay and Medicaid budgets; Calif. mental health grants; NYU ER reopens

State highlights: Home care workers' pay and Medicaid budgets; Calif. mental health grants; NYU ER reopens

Methadone safety: New clinical practice guideline from American Pain Society

Methadone safety: New clinical practice guideline from American Pain Society

Researcher develops novel IBT to help opioid-dependent Vermonters

Researcher develops novel IBT to help opioid-dependent Vermonters

2014 PAINWeekEnd Regional Conference to highlight health crises of inadequate pain management

2014 PAINWeekEnd Regional Conference to highlight health crises of inadequate pain management

Study shows important parallels between epidemic of HIV/AIDS and opioid addiction

Study shows important parallels between epidemic of HIV/AIDS and opioid addiction

Researchers find unusual mutation strongly linked to rare liver cancer that affects teens

Researchers find unusual mutation strongly linked to rare liver cancer that affects teens

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.